Determination of Mitochondrial Respiration and Glycolysis in Ex Vivo Retinal Tissue Samples
August 4th, 2021
4.4K views
Described here is a detailed protocol for performing mitochondrial stress assay and glycolytic rate assay in ex vivo retinal tissue samples using a commercial bioanalyzer.
Overview
This article presents a detailed protocol for real-time measurement of mitochondrial respiration and glycolysis in freshly dissected ex vivo mouse retinal tissue. Using microplate-based fluorescence technology, the method enables direct assessment of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in intact retinal punches, providing insights into retinal metabolism under physiological and disease conditions.
Key Study Components
Area of Science
- Retinal physiology
- Cellular metabolism
- Bioenergetics
Background
- Mitochondrial respiration is essential for energy production in retinal photoreceptors, which have high metabolic demands.
- Photoreceptors also exhibit high aerobic glycolysis, similar to cancer cells.
- Most high-throughput metabolic assays are optimized for cultured cells, not intact tissues.
- Accurate measurement of metabolic activity in intact retina is crucial for understanding homeostasis, aging, and disease.
Purpose of Study
- To provide a step-by-step protocol for measuring mitochondrial respiration and glycolysis in ex vivo mouse retina.
- To adapt microplate-based assays for use with intact tissue samples.
- To enable investigation of metabolic mechanisms in retinal development, aging, and disease models.
Methods Used
- Dissection of adult mouse retina and preparation of 1 mm punch discs.
- Placement of retinal punches onto pre-coated mesh inserts for microplate-based analysis.
- Measurement of OCR (mitochondrial respiration) and ECAR (glycolysis) using fluorescence-based sensors.
- Application of metabolic modulators (Bam15, rotenone, antimycin A, 2-deoxy-D-glucose) to assess reserve capacities.
Main Results
- The protocol enables real-time analysis of mitochondrial and glycolytic activity in intact retinal tissue.
- Injection of Bam15 increases OCR to maximal levels, while rotenone and antimycin A inhibit mitochondrial respiration, revealing reserve capacity.
- Glycolytic reserve is assessed by inhibiting mitochondrial respiration and then blocking glycolysis with 2-deoxy-D-glucose.
- The method is sensitive to tissue quality and dissection speed, requiring skilled handling for reproducible results.
Conclusions
- This protocol allows direct measurement of metabolic function in ex vivo retina, overcoming limitations of cell culture-based assays.
- It is applicable to studies of retinal development, aging, and disease, and may be adapted for other tissues.
- Reliable data depend on high-quality tissue preparation and normalization to DNA or protein content.
Frequently Asked Questions
What are the main metabolic pathways measured by this protocol?
The protocol measures mitochondrial respiration (via oxygen consumption rate, OCR) and glycolysis (via extracellular acidification rate, ECAR) in intact retinal tissue.
Why is it important to use intact retinal tissue instead of cultured cells?
Intact tissue preserves the native cellular environment and interactions, providing more physiologically relevant metabolic data compared to cultured cells.
What are the critical steps for successful retinal punch preparation?
Obtaining high-quality retinal punch discs requires skilled dissection, minimizing tissue damage, and limiting total dissection time to under 1.5 hours.
How are mitochondrial and glycolytic reserve capacities assessed?
Reserve capacities are determined by sequentially applying metabolic modulators: Bam15 uncouples mitochondria to reveal maximal OCR, while rotenone and antimycin A inhibit respiration; glycolytic reserve is measured by inhibiting mitochondria and then blocking glycolysis with 2-deoxy-D-glucose.
Can this protocol be adapted for other tissues?
Yes, while optimized for retina, the protocol has potential for adaptation to other tissue types with appropriate modifications.
How should the metabolic data be normalized?
Data can be normalized to DNA or protein content of each retinal punch to account for sample variability.
What applications does this method have in retinal research?
It can be used to study metabolic changes during development, aging, and in disease models, as well as to assess tissue preference for different fuel substrates.
Executive Industry Relevance
Direct measurement of mitochondrial respiration and glycolysis in ex vivo retinal tissue enables high-fidelity metabolic profiling at early discovery and target validation stages. This approach provides predictive confidence for mechanistic de-risking in disease-relevant systems, supporting translational continuity from discovery through preclinical research. The protocol's adaptability to intact tissues addresses a critical gap in portfolio decision-making for metabolic and neurodegenerative disease programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of metabolic pathway function in physiologically relevant retinal tissue.
- Supports mechanistic de-risking by quantifying mitochondrial and glycolytic reserve capacities.
- Facilitates functional target validation in models of retinal degeneration and aging.
Screening & Assay Development
- Prepares validated ex vivo tissue systems for downstream metabolic screening workflows.
- Delivers quantitative OCR and ECAR outputs for assay standardization and reproducibility.
- Enables reliable evaluation of metabolic modulators in intact tissue context.
Translational & Preclinical Research
- Aligns metabolic readouts with disease-relevant phenotypes in retinal models.
- Supports continuity from discovery through preclinical validation by enabling direct tissue analysis.
- Provides risk-adjusted data for advancement decisions in metabolic and neurodegenerative pipelines.
Pipeline & Workflow Integration
This protocol bridges early discovery and preclinical research by enabling direct metabolic assessment in intact retinal tissue, supporting lead identification and translational biomarker development.
- Discovery Biology: Facilitates hypothesis testing and pathway clarification in native tissue environments.
- Screening: Provides reproducible, quantitative OCR and ECAR measurements for compound evaluation.
- Analytics: Generates real-time metabolic traces and reserve capacity metrics for comparative analysis.
- Translational Research: Connects metabolic function to disease progression and therapeutic response in preclinical models.
- Enterprise Reuse: Offers a reusable platform adaptable to other tissue types for broader portfolio impact.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in metabolic target validation.
- Operational Value: Standardizes metabolic assays for reproducibility and scalability across tissue types.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by providing robust functional data.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of metabolic and neurodegenerative disease assets.
Implementation Considerations
- Requires skilled tissue dissection and handling expertise for reproducible results.
- Needs access to microplate-based fluorescence instrumentation and analytical infrastructure.
- Demands cross-team standardization of tissue preparation and assay protocols.
- May require adaptation for different tissue types or disease models.
- Data normalization to DNA or protein content is essential for accurate interpretation.
Biopharma FAQs
Why does null hypothesis testing matter for mitochondrial reserve capacity analysis?
Null hypothesis testing ensures that observed changes in mitochondrial reserve capacity, measured by OCR after Bam15 and inhibitor injections, are statistically significant and not due to random variation, supporting robust target validation decisions.
How does independent variable isolation fit into OCR and ECAR measurement workflows?
By sequentially applying metabolic modulators such as Bam15, rotenone, antimycin A, and 2-deoxy-D-glucose, the protocol isolates the effects of each variable on mitochondrial and glycolytic activity, enabling precise attribution of functional changes.
What do quantitative OCR and ECAR measurements enable in retinal tissue assays?
Quantitative OCR and ECAR outputs provide real-time, reproducible metrics of mitochondrial respiration and glycolysis, supporting comparative analysis across conditions and informing mechanistic de-risking in discovery pipelines.
Why are replication requirements critical for cross-functional metabolic assay collaboration?
Replication ensures that metabolic data from retinal punch assays are reliable and reproducible, facilitating cross-team data integration and supporting enterprise-wide decision-making in R&D programs.
What statistical analysis capabilities are required before implementing metabolic reserve assays?
Robust statistical analysis, including normalization to DNA or protein content and significance testing of OCR and ECAR changes, is essential to validate assay outputs and support confident advancement of discovery and preclinical projects.
Chapters in this video
0:04
Introduction
1:21
Hydrating Sensor Cartridge and Preparation of the Assay Medium
1:55
Coating Mesh Inserts of Islet Capture Microplate
2:35
Retinal Dissection and Retinal Punch Preparation
4:21
Loading the Sensor Cartridge Injection Ports and Calibration
5:09
Loading the Islet Capture Plate and Running Assay
6:31
Results: Mitochondrial Stress and Glycolytic Rate Assays
7:51
Conclusion
